不同孕周未足月胎膜早破期待治疗的临床观察

Clinical Observation of Expectant Treatment of Premature Rupture of Membranes in Different Gestational Weeks

目的:分析不同孕周未足月胎膜早破期待治疗的临床效果。方法:研究阶段为2017年1月~2018年12月,共纳入研究对象80例,均为未足月胎膜早破孕妇,根据不同孕周进行分组。全部接受相应检查,并采取期待治疗,分析临床效果。结果:B组期待治疗时间明显长于A组和C组,差异显著,P<0.05;A组、C组期待治疗时间差异无统计学意义,P>0.05;3组母体感染率差异无统计学意义,P>0.05;A组胎儿窘迫发生率、新生儿窒息发生率、死亡率明显高于B组、C组,差异显著,P<0.05。结论:针对妊娠32~34+6周的未足月胎膜早破孕妇采取期待治疗可改善妊娠结局,对于提高产妇、新生儿生活质量有重要意义,但是需确保无宫内感染、胎儿窘迫等危险因素。

Objective:To analyze the clinical effects of expectant treatment of premature rupture of membranes in different gestational ages. Methods:80 cases of pregnant women with premature rupture of membranes treated in a hospital from January 2017 to December 2018 were included in the study and grouped according to different gestational ages.All pregnant women received the appropriate examination and the expected treatment,then the clinical effect were analyzed. Results:The expectant treatment time in group B was significantly longer than that in group A and group C,with a significant difference(P<0.05). There was no significant difference in expected treatment time between groups A and C(P>0.05). There was no significant difference in maternal infection rates among the three groups(P>0.05). The incidence of fetal distress,incidence of neonatal asphyxia,and mortality in the group A were significantly higher those in the group B and group C. The difference was significant(P<0.05). Conclusion:The expectant treatment for the pregnant women with premature rupture of membranes at 32 to 34+6 weeks of gestation can improve the outcome of pregnancy,which is of great significance to the improvement of the quality of life of the pregnant women and newborns. However,it is necessary to ensure that there is no intrauterine infection,fetal distress and other risk factors.